[Clinical experiences with the new analgesic tilidin-HC1].
D000588:Amines / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003509:Cyclohexanecarboxylic Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D005221:Fatigue / Q000209:etiology; D005260:Female; D006801:Humans; D007677:Kidney Function Tests; D008111:Liver Function Tests; D008297:Male; D009892:Opium / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy*; D010919:Placebos; D011720:Pyrazoles / Q000627:therapeutic use; D013451:Sulfonic Acids / Q000627:therapeutic use; D013997:Time Factors; D014474:Unconsciousness / Q000209:etiology; D014717:Vertigo / Q000209:etiology; D014839:Vomiting / Q000209:etiology
D000588:Amines; D003509:Cyclohexanecarboxylic Acids; D010919:Placebos; D011720:Pyrazoles; D013451:Sulfonic Acids; D009892:Opium
Klinische Erfahrungen mit dem neuen Analgetikum Tilidin-HC1.